Stolze, T.
Franke, S.
Haybaeck, J.
Moehler, M.
Grimminger, P. P.
Lang, H.
Roth, W.
Gockel, I.
Kreuser, N.
Bläker, H.
Wittekind, C.
Lordick, F.
Vieth, M.
Veits, L.
Waidmann, O.
Lingohr, P.
Peitz, U.
Schildberg, C.
Kruschewski, M.
Vassos, N.
Goni, E.
Bruns, C. J.
Ridwelski, K.
Wolff, S.
Lippert, H.
Schumacher, J.
Malfertheiner, P.
Venerito, M. http://orcid.org/0000-0001-8581-0974
Funding for this research was provided by:
Otto-von-Guericke-Universität Magdeburg
Article History
Received: 21 December 2021
Accepted: 8 February 2022
First Online: 25 February 2022
Declarations
:
: TS, JH, WR, IG, NK, HB, CW, FL, MiV, LV, PL, IK, UP, CS, MK, NV, EG, KR, CB, SW, HL, JS and PM have nothing to declare. SF received honoraria from Merck Serono, AstraZeneca, BMS and Roche. MM received personal fees and/or grants from Falk foundation, MSD, Lilly, Roche, Pfizer, Amgen, Bristol-Myers Squibb, Merck Serono, MCI group and Taiho. PPG is receiving funds as proctor for Intuitive Surgical and advisory board member of Medicaroid Europe GmbH. OW received honoraria from Abbvie, Amgen, AstraZeneca, Basilea, Bayer, BMS, Celgene, Eisai, Gilead, Incyte, Ipsen, Medac, Merck Serono, MSD, Novartis, Roche, Servier and Shire. MaV received honoraria from Nordic Pharma, Merck Serono, Novartis, Bayer Vital, Lilly and Sirtex, and is a member of the advisory boards of Ipsen, Lilly, Nordic Pharma, Bayer Vital, BMS, MSD, Eisai and Amgen.
: This study was approved by the Ethics Committee of the Otto-von-Guericke University Hospital in Magdeburg on the 15th of November 2019 (Number 151/19), as was the staR-project on the 29th of January 2013 (Number 170/12). Patients provided written informed consent and permission to contact physicians involved in their tumor therapy for information.